726 related articles for article (PubMed ID: 15659304)
1. Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure.
Wada K; Fujimori A; Matsukawa U; Arai Y; Sudoh K; Yatsu T; Sasamata M; Miyata K
Eur J Pharmacol; 2005 Jan; 507(1-3):145-51. PubMed ID: 15659304
[TBL] [Abstract][Full Text] [Related]
2. Effect of the vasopressin receptor antagonist conivaptan in rats with heart failure following myocardial infarction.
Wada K; Tahara A; Arai Y; Aoki M; Tomura Y; Tsukada J; Yatsu T
Eur J Pharmacol; 2002 Aug; 450(2):169-77. PubMed ID: 12206855
[TBL] [Abstract][Full Text] [Related]
3. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure.
Yatsu T; Tomura Y; Tahara A; Wada K; Kusayama T; Tsukada J; Tokioka T; Uchida W; Inagaki O; Iizumi Y; Tanaka A; Honda K
Eur J Pharmacol; 1999 Jul; 376(3):239-46. PubMed ID: 10448882
[TBL] [Abstract][Full Text] [Related]
5. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
Henderson KK; Danzi S; Paul JT; Leya G; Klein I; Samarel AM
Circ Heart Fail; 2009 May; 2(3):243-52. PubMed ID: 19808346
[TBL] [Abstract][Full Text] [Related]
6. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
Nekooeian AA; Tabrizchi R
Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
Nekooeian AA; Tabrizchi R
Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898
[TBL] [Abstract][Full Text] [Related]
8. Improved outcomes of cardiopulmonary resuscitation in rats with myocardial infarction treated with allogenic bone marrow mesenchymal stem cells.
Wang T; Tang W; Sun S; Ristagno G; Xu T; Weil MH
Crit Care Med; 2009 Mar; 37(3):833-9. PubMed ID: 19237885
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of a calcium channel promoter, BAY y 5959, are preserved after chronic administration in ischemic heart failure in conscious dogs.
Yi GH; Burkhoff D; Zhang H; Zhu SM; Zwas D; Wang J
J Pharmacol Exp Ther; 1998 Aug; 286(2):760-6. PubMed ID: 9694931
[TBL] [Abstract][Full Text] [Related]
10. Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure.
Qiu CB; Qiu CS; Hess P; Clozel JP; Clozel M
Acta Pharmacol Sin; 2001 Jun; 22(6):541-8. PubMed ID: 11747762
[TBL] [Abstract][Full Text] [Related]
11. The effect of AT1 receptor antagonist on chronic cardiac response to coronary artery ligation in rats.
Sladek T; Sladkova J; Kolar F; Papousek F; Cicutti N; Korecky B; Rakusan K
Cardiovasc Res; 1996 Apr; 31(4):568-76. PubMed ID: 8689648
[TBL] [Abstract][Full Text] [Related]
12. Local controlled intramyocardial delivery of platelet-derived growth factor improves postinfarction ventricular function without pulmonary toxicity.
Hsieh PC; MacGillivray C; Gannon J; Cruz FU; Lee RT
Circulation; 2006 Aug; 114(7):637-44. PubMed ID: 16894033
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of the therapeutic effect of astragalus membranaceus on sodium and water retention in experimental heart failure.
Ma J; Peng A; Lin S
Chin Med J (Engl); 1998 Jan; 111(1):17-23. PubMed ID: 10322646
[TBL] [Abstract][Full Text] [Related]
14. Selective vasopressin inhibition in rats with heart failure decreases afterload and results in venodilatation.
Raya TE; Gay RG; Goldman S
J Pharmacol Exp Ther; 1990 Dec; 255(3):1015-20. PubMed ID: 2262890
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
Mao ZL; Stalker D; Keirns J
Clin Ther; 2009 Jul; 31(7):1542-50. PubMed ID: 19695403
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of the extract from Corydalis yanhusuo in rats with heart failure following myocardial infarction.
Wu L; Ling H; Li L; Jiang L; He M
J Pharm Pharmacol; 2007 May; 59(5):695-701. PubMed ID: 17524235
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cardioprotective effects of mibefradil and ramipril in stroke-prone spontaneously hypertensive rats.
Xia QG; Reinecke A; Dorenkamp M; Storz C; Bitterling H; Penz S; Cleutjens J; Daemen MJ; Simon R; Unger T
Acta Pharmacol Sin; 2004 Jun; 25(6):763-8. PubMed ID: 15169629
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: a dose-ranging pilot study.
Goldsmith SR; Elkayam U; Haught WH; Barve A; He W
J Card Fail; 2008 Oct; 14(8):641-7. PubMed ID: 18926434
[TBL] [Abstract][Full Text] [Related]
19. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation.
Thai H; Guarraia D; Johnson N; Goldman S; Gaballa MA
J Cardiovasc Pharmacol; 2007 Dec; 50(6):703-7. PubMed ID: 18091589
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of doxycycline, losartan, and their combination in the prevention of post-infarction remodeling in rats].
Yang YJ; Zhang P; Ruan YM; Chen X; Zhou YW; Tian Y; Gao RL; Chen ZJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):479-85. PubMed ID: 16178444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
